Peptides and peptidomimetics as a therapeutic candidate for the treatment of COVID-19: A brief review.
Indian J Pharmacol
; 55(1): 53-58, 2023.
Article
in English
| MEDLINE | ID: covidwho-2267521
ABSTRACT
Novel SARS-CoV-2 (COVID-19) is affecting worldwide as declared pandemic by the WHO. Various repositioning and novel therapeutic agents are being evaluated under different clinical setups; however, there is no promising therapeutic agent reported to date. Small molecules like peptides have their popularity as their specificity, delivery, and synthesizability as promising therapeutic agents. In this study, we have reviewed the published literature describing peptide designing, in silico binding mode, antiviral activity, preventive measures, and in vivo assessments. Here, we reported all the results which are promising against SARS-CoV-2 as therapeutic and preventive (vaccine candidates), and their status in the drug development process.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Peptidomimetics
/
COVID-19
Type of study:
Experimental Studies
/
Prognostic study
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
Indian J Pharmacol
Year:
2023
Document Type:
Article
Affiliation country:
Ijp.ijp_700_22
Similar
MEDLINE
...
LILACS
LIS